Baxter International Inc $75.09

up +0.18


29/8/2014 11:49 AM  |  NYSE : BAX  
Industries : Health Services / Medical Instruments & Supplies
Get Trend Analysis Icon Get BAX Trend Analysis - it has underperformed the S&P 500 by 16%

Partner Headlines

  1. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  2. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga
  3. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  4. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  5. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  6. Diamond Hill Capital Comments on Baxter International Inc

    GuruFocus
  7. Baxter Q2 Earnings Beat Estimates, But Guidance Soft

    IBD
  8. Earnings Scheduled For July 17, 2014

    Benzinga
  9. Hemophilia Drugs, Gambro Deal Boost Baxter's Growth

    IBD
  10. Biogen Hemophilia Drugs Launch Into The Unknown

    IBD
  11. Why I Bought Baxter International

    GuruFocus
  12. Grifols Grows Into New Markets, Products Via Buyouts

    IBD
  13. Cyberonics Shocks Investors With Weak Profit Guidance

    IBD
  14. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus
  15. 7 Stocks Building Shareholder Returns with Higher Dividends

    GuruFocus
  16. Medical Devices Face Onslaught Of Pricing Pressure

    IBD
  17. Earnings Scheduled For April 17, 2014

    Benzinga
  18. Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11 ...

    Benzinga
  19. 4 Top Stocks in the Medical Device Sector

    GuruFocus
  20. Analysts Warm To Baxter's Split Announcement

    IBD
  21. Alarming Spinoff: ADT Debt Soars, Stock Plunges

    YCharts
  22. We Are Confident About Baxter's Plan to Create Two Separate Health Care ...

    GuruFocus
  23. For The Record

    IBD
  24. Morgan Stanley Welcomes Shift in Sentiment on Baxter International

    Benzinga
  25. Not Too Late to Buy Baxter, Jim Cramer Says

    Benzinga
  26. Baxter To Split In 2 By 2015

    IBD
  27. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
  28. Mid-Afternoon Market Update: Inovio Rallies on Vaccine Award; Citigroup ...

    Benzinga
  29. Mid-Day Market Update: US Stocks Fall; Citigroup Shares Slip After Failed ...

    Benzinga
  30. Stocks Turn Down Near Midday; Diamondback Tops U.S. Oil Rally

    IBD
  31. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  32. Merck Snags Baxter Executive As CFO

    FoxBusiness
  33. Benzinga's Volume Movers

    Benzinga
  34. Mid-Morning Market Update: Markets Mostly Flat; Lululemon Profit Beats ...

    Benzinga
  35. Stocks Cling To Narrow Gains; Baxter International, Alcoa Up

    IBD
  36. Morgan Stanley Offers Quick Thoughts on Eloctate and Strategic Action Related ...

    Benzinga
  37. Morning Market Movers

    Benzinga
  38. Benzinga's Top #PreMarket Gainers

    Benzinga
  39. Baxter to Split Itself into Two Companies

    FoxBusiness
  40. UPDATE: Baxter Details Plan to Create Two Separate Global Healthcare Cos.

    Benzinga
  41. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  42. Market Wrap For March 17: Investors Focused On Economic Data Instead Of ...

    Benzinga
  43. UPDATE: Goldman Sachs Downgrades Baxter International as Increased Dependence ...

    Benzinga
  44. Morgan Stanley's View of Baxter International is Not Changed by Rigosertib's ...

    Benzinga
  45. How To Invest: Shakeout + 3 Offers Early Entry

    IBD
  46. BAXTER INT'L

    IBD
  47. Earnings Scheduled For January 23, 2014

    Benzinga
  48. Diamond Hill Capital Comments on Baxter International

    GuruFocus
  49. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD
  50. Celgene To Release Earnings At J.P. Morgan Event Mon.

    IBD
Trading Center